Filing Details
- Accession Number:
- 0001181431-13-015496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-07 21:05:47
- Reporting Period:
- 2013-03-06
- Filing Date:
- 2013-03-07
- Accepted Time:
- 2013-03-07 21:05:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1389870 | Omni Bio Pharmaceutical Inc. | OMBP | Biological Products, (No Disgnostic Substances) (2836) | 208097969 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327324 | E D Vicki Barone | 5350 South Roslyn Suite 430 Greenwood Village CO 80111 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-03-06 | 300,000 | $0.25 | 417,750 | No | 4 | S | Indirect | By GVC Partners LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By GVC Partners LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 737,437 | Direct | |
Common Stock | 100,000 | Indirect | By GVC Capital LLC |
Footnotes
- On March 6, 2013, GVC Partners LLC sold 100,000 shares of the issuer's common stock to GVC Capital LLC and 100,000 shares of the issuer's common stock to the reporting person. These transactions are treated soley as a change in the form of beneficial ownership of the reporting person.
- The reporting person is a Senior Managing Partner of GVC Partners LLC. GVC Partners LLC is the sole member of GVC Capital LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of such securities for purposes of Section 16 or for any other purpose.